Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Medtronic

evt | Article | March 2024

Roundtable Discussion: Chronic Venous Disease Treatment Options

With Ramona Gupta, MD, FSIR; Kathleen Ozsvath, MD, FACS; and Michael Shao, MD, RPVI

Sponsored by Medtronic

evt | Article | March 2025

Hypersensitivity Reaction With Cyanoacrylate Glue: Patient Selection, Technical Considerations, and Management

Approach to hypersensitivity management after endovenous ablation.

By Eri Fukaya, MD, PhD; Leigh Ann O’Banion, MD, RPVI; Michael Y. Shao, MD, RPVI; Carl Fastabend, MD; Robert A. Edwards, DO; Misaki M. Kiguchi, MD, MBA, FACS, RPVI; Michael J. Cumming, MD, MBA, FRPC; and Kathleen Gibson, MD

Sponsored by The PERT Consortium™

evt | Article | July 2019 Supplement

Pulmonary Embolism: An International Crisis

By Aaron S. Weinberg, MD; Michael R. Jaff, DO; and Victor F. Tapson, MD

evt | Article | April 2014

Gastric Embolization to Treat Obesity

The rationale behind this therapeutic option for obese patients.

By Michael Wolf, MD; Susie Park, MD; and Gary Siskin, MD, FSIR

Advertisement

Advertisement

evt | Article | January/February 2003

The Vascular Lab

What technology and equipment will you need to create an office-based lab?

By MICHAEL R. JAFF, DO

evt | Article | June 2007

Embolic Protection Questions Answered

What is the embolic risk for endovascular SFA intervention? When is embolic protection necessary?

By Michael Wholey, MD, MBA; William C.L. Wu, MD; Boulos Toursarkissian, MD; Raj Suri, MD; Marco Cura, MD; and Martin G. Radvany, MD

evt | Article | November 2017

Identifying the Appropriate Thoracic Device Size

How to correctly size a thoracic device in diameter, landing zone, and length.

By Michael E. Barfield, MD, and Thomas S. Maldonado, MD

evt | Article | August 2016

Five Essential Components to Treating Peripheral Artery Disease and Critical Limb Ischemia

By Nicholas J. Petruzzi, MD; Lori Richwine, DO; Rajesh Patel, MD; and Michael Schmidling, MD

evt | Article | May 2014

Distal Embolization During Percutaneous Lower Limb Interventions

Identifying specific patients and lesion types that are at high risk of distal embolization could result in improved limb salvage rates and reduced morbidity and mortality.

By Leonardo Marques, MD; Michael Preiss, MD; Stephanie Lehrke, MD; Silke Hopf-Jensen, MD; Joana Carvalho, MD; and Prof. Stefan Müller-Hülsbeck, MD

evt | Article | June 2018

Creating CLI Teams

The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.

By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants

evt | Article | November 2020

Thoracic Aortic Trauma: Who Gets Endovascular Intervention and How to Optimize Outcomes

The management of blunt thoracic aortic injury, from mechanism of injury and history of repair to indications for endovascular intervention, TEVAR techniques, and potential complications.

By Matthew Blecha, MD; Corinne Bunn, MD; Michael Soult, MD; and Vivian Gahtan, MD

evt | Article | September 2014

Milestone Cases in Endovascular Trauma Therapy

Recollections of key experiences in the history and development of this life-saving therapy.

By Federico E. Parodi, MD, and Juan C. Parodi, MD

evt | News | August 28, 2017

SPYRAL HTN-OFF MED Results Encourage Medtronic to Pursue Renal Denervation Pivotal Trial

August 28, 2017—Medtronic announced that it will conduct a new renal denervation (RDN) pivotal trial after the positive first results from the sham-controlled SPYRAL HTN-OFF MED study in patients with high blood pressure were presented by the Co-Principal Investigator, Professor Michael Böhm, MD, at the European Society of Cardiology's ESC Congress 2017, held August 26–30 in Barcelona, Spain.

evt | News | July 24, 2024

SoniVie Gains IDE Approval for THRIVE Pivotal Trial of Tivus RDN System

July 24, 2024—SoniVie announced that the FDA recently approved an investigational device exemption for the THRIVE pivotal study of the company’s Tivus therapeutic intravascular ultrasound system for renal denervation (RDN) therapy in patients with resistant hypertension.

evt | News | March 28, 2014

Medtronic Presents SYMPLICITY HTN-3 Data and Commits to Further Clinical Investigations

March 29, 2014—Medtronic, Inc. (Minneapolis, MN) announced that the full results of the SYMPLICITY HTN-3 clinical trial were presented in a late-breaking session at the ACC.14: 63rd annual scientific sessions of the American College of Cardiology and published simultaneously online ahead of print in The New England Journal of Medicine.

evt | News | March 11, 2026

Verve’s United States Pilot Trial of Renal Pelvic Denervation Therapy Enrolls First Patient

March 11, 2026—Verve Medical, a developer of noninvasive renal pelvic denervation (RPD) technology, announced the treatment of the first patient in its randomized, double-blinded United States pilot clinical trial for the treatment of uncontrolled hypertension.

evt | News | December 17, 2013

Medtronic Begins SYMPLICITY HTN-4 Trial of Renal Denervation for Moderate Uncontrolled Hypertension

December 17, 2013—Medtronic, Inc. (Minneapolis, MN) announced that the first patients were randomized in the SYMPLICITY HTN-4 trial, which is evaluating the company’s Symplicity renal denervation system in patients with moderate uncontrolled hypertension (defined as systolic blood pressure ≥ 140 and < 160 mm Hg, despite treatment with three or more antihypertensive medications of different classes).

evt | News | April 15, 2015

Boston Scientific Begins Novel REDUCE-HTN: REINFORCE Study of Vessix Renal Denervation System

April 16, 2015—Boston Scientific Corporation announced the initiation of the REDUCE-HTN: REINFORCE study, which is taking a new approach to evaluate the performance of the Vessix renal denervation system by using a novel design to isolate the effects of the therapy in patients with high blood pressure.

evt | News | October 15, 2021

ReCor’s Paradise Renal Denervation System Studied in REQUIRE Trial in Japan and Korea

October 15, 2021—Otsuka Medical Devices Co., Ltd. (OMD), a subsidiary of Otsuka Holdings, Inc., and its subsidiary, ReCor Medical, Inc., announced results from the REQUIRE trial of ReCor’s Paradise ultrasound renal denervation system for the treatment of hypertension that was conducted in Japan and Korea.

evt | News | March 29, 2014

Six-Month Analysis of Global SYMPLICITY Registry Supports Safety of Medtronic's Renal Denervation System

March 30, 2014—Medtronic, Inc. (Minneapolis, MN) announced to the presentation of an analysis of 6-month follow-up data from the first 1,000 patients enrolled in the Global SYMPLICITY Registry.


1
2
3

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button